[One case of newly-onset liver cancer and dual drug-resistance during treatment of hepatitis B cirrhosis with nucleos(t)ide analogues].
Department of Gastroenterology, the First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
C Y
CY
Li
Department of Gastroenterology, the First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
J Y
JY
Pan
Department of Infectious Diseases, the Sixth People's Hospital of Dalian, Dalian 116031, China.
A P
AP
Yang
D000998:Antiviral Agents / Q000008:administration & dosage*; D024882:Drug Resistance, Viral / Q000187:drug effects; D006509:Hepatitis B / Q000188:drug therapy*; D019694:Hepatitis B, Chronic / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D008103:Liver Cirrhosis; D008113:Liver Neoplasms / Q000175:diagnosis / Q000473:pathology; D009705:Nucleosides / Q000008:administration & dosage* / Q000627:therapeutic use*; D009711:Nucleotides / Q000008:administration & dosage*; D016896:Treatment Outcome
D000998:Antiviral Agents; D009705:Nucleosides; D009711:Nucleotides